A citation-based method for searching scientific literature

Ellie-May Beaman, Susan A Brooks. Histol Histopathol 2014
Times Cited: 17







List of co-cited articles
77 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
447
58

GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
44
35

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
121
35

GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Mei-Chun Lin, Miao-Juei Huang, Chiung-Hui Liu, Tsung-Lin Yang, Min-Chuan Huang. Oral Oncol 2014
55
35

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
431
35


All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
344
29

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
73
29

Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu,[...]. Cancer Res 2011
73
29

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
58
23

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
Miao-Juei Huang, Rey-Heng Hu, Chih-Hsing Chou, Chia-Lang Hsu, Ya-Wen Liu, John Huang, Ji-Shiang Hung, I-Rue Lai, Hsueh-Fen Juan, Sung-Liang Yu,[...]. Oncotarget 2015
27
23


Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
55
23

Glycosylation in cellular mechanisms of health and disease.
Kazuaki Ohtsubo, Jamey D Marth. Cell 2006
23

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
46
23

Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
H H Wandall, H Hassan, E Mirgorodskaya, A K Kristensen, P Roepstorff, E P Bennett, P A Nielsen, M A Hollingsworth, J Burchell, J Taylor-Papadimitriou,[...]. J Biol Chem 1997
242
23

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Yunus Emre Tarhan, Taigo Kato, Miran Jang, Yoshimi Haga, Koji Ueda, Yusuke Nakamura, Jae-Hyun Park. Neoplasia 2016
25
23

The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
Thomas A Gerken, Leslie Revoredo, Joseph J C Thome, Lawrence A Tabak, Malene Bech Vester-Christensen, Henrik Clausen, Gagandeep K Gahlay, Donald L Jarvis, Roy W Johnson, Heather A Moniz,[...]. J Biol Chem 2013
55
23

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Ok-Seon Kwon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, Yoon L Choi, Young Soo Choi, Jhingook Kim,[...]. Oncotarget 2015
20
23

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
60
23


Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
Joana Gomes, Nuno T Marcos, Nora Berois, Eduardo Osinaga, Ana Magalhães, João Pinto-de-Sousa, Raquel Almeida, Fátima Gärtner, Celso A Reis. J Histochem Cytochem 2009
46
17


Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
S Kitada, S Yamada, A Kuma, S Ouchi, T Tasaki, A Nabeshima, H Noguchi, K-Y Wang, S Shimajiri, R Nakano,[...]. Br J Cancer 2013
51
17

Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness.
David J Gill, Keit Min Tham, Joanne Chia, Shyi Chyi Wang, Catharina Steentoft, Henrik Clausen, Emilie A Bard-Chapeau, Frederic A Bard. Proc Natl Acad Sci U S A 2013
124
17

The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
Hans H Wandall, Fernando Irazoqui, Mads Agervig Tarp, Eric P Bennett, Ulla Mandel, Hideyuki Takeuchi, Kentaro Kato, Tatsuro Irimura, Ganesh Suryanarayanan, Michael A Hollingsworth,[...]. Glycobiology 2007
70
17

The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
H Hassan, C A Reis, E P Bennett, E Mirgorodskaya, P Roepstorff, M A Hollingsworth, J Burchell, J Taylor-Papadimitriou, H Clausen. J Biol Chem 2000
119
17


The catalytic and lectin domains of UDP-GalNAc:polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection.
Jayalakshmi Raman, Timothy A Fritz, Thomas A Gerken, Oliver Jamison, David Live, Mian Liu, Lawrence A Tabak. J Biol Chem 2008
60
17

Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
E P Bennett, H Hassan, U Mandel, E Mirgorodskaya, P Roepstorff, J Burchell, J Taylor-Papadimitriou, M A Hollingsworth, G Merkx, A G van Kessel,[...]. J Biol Chem 1998
179
17

GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung,[...]. Pharmacogenomics 2016
12
25

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. Medicine (Baltimore) 2016
11
27

Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
Shin-Yun Liu, Chia-Tung Shun, Kuan-Yu Hung, Hsueh-Fen Juan, Chia-Lang Hsu, Min-Chuan Huang, I-Rue Lai. Oncotarget 2016
25
17

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
11

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
85
11




GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
Wan-Ling Ho, Chih-Hsing Chou, Yung-Ming Jeng, Meng-Yao Lu, Yung-Li Yang, Shiann-Tarng Jou, Dong-Tsamn Lin, Hsiu-Hao Chang, Kai-Hsin Lin, Wen-Ming Hsu,[...]. Oncotarget 2014
24
11

Glycosyltransferases as Markers for Early Tumorigenesis.
Ulrich Andergassen, Friederike Liesche, Alexandra C Kölbl, Matthias Ilmer, Stefan Hutter, Klaus Friese, Udo Jeschke. Biomed Res Int 2015
15
13

Two opposing roles of O-glycans in tumor metastasis.
Shigeru Tsuboi, Shingo Hatakeyama, Chikara Ohyama, Minoru Fukuda. Trends Mol Med 2012
43
11

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
C Gu, T Oyama, T Osaki, J Li, M Takenoyama, H Izumi, K Sugio, K Kohno, K Yasumoto. Br J Cancer 2004
40
11

GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Yidong Liu, Weisi Liu, Le Xu, Haiou Liu, Weijuan Zhang, Yu Zhu, Jiejie Xu, Jianxin Gu. J Urol 2014
10
20

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Nora Berois, Charles-Henry Gattolliat, Enrique Barrios, Laura Capandeguy, Sétha Douc-Rasy, Dominique Valteau-Couanet, Jean Bénard, Eduardo Osinaga. Clin Chem 2013
33
11

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
209
11

Cancer statistics, 2014.
Rebecca Siegel, Jiemin Ma, Zhaohui Zou, Ahmedin Jemal. CA Cancer J Clin 2014
11

GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.
Bachir Niang, Liyuan Jin, Xixi Chen, Xiaohan Guo, Hongshuo Zhang, Qiong Wu, Arshad Ahmed Padhiar, Min Xiao, Deyu Fang, Jianing Zhang. Mol Cell Biochem 2016
17
11

The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain.
Rajendra P Pangeni, Prasanna Channathodiyil, David S Huen, Lawrence W Eagles, Balraj K Johal, Dawar Pasha, Natasa Hadjistephanou, Oliver Nevell, Claire L Davies, Ayobami I Adewumi,[...]. Clin Epigenetics 2015
47
11

Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
Tomomi Kubota, Tomoo Shiba, Shigemi Sugioka, Sanae Furukawa, Hiromichi Sawaki, Ryuich Kato, Soichi Wakatsuki, Hisashi Narimatsu. J Mol Biol 2006
82
11

Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
Thomas A Gerken, Oliver Jamison, Cynthia L Perrine, Jeremy C Collette, Helen Moinova, Lakshmeswari Ravi, Sanford D Markowitz, Wei Shen, Himatkumar Patel, Lawrence A Tabak. J Biol Chem 2011
104
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.